Board of Directors

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol-Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.

Giovanni Caforio

Giovanni Caforio, M.D.

Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb 

Triangle Icon
Peter J. Arduini

Peter J. Arduini

President and Chief Executive Officer of Integra LifeSciences Holdings Corporation

Triangle Icon
Robert J. Bertolini

Robert J. Bertolini

Former President and Chief Financial Officer of Bausch & Lomb

Triangle Icon
 Matthew W. Emmens

Matthew W. Emmens

Retired CEO and Chairman of Shire Pharmaceuticals

Triangle Icon
Michael Grobstein

Michael Grobstein

Retired Vice Chairman of Ernst & Young LLP

Triangle Icon
Alan J. Lacy

Alan J. Lacy

Non-Executive Chairman, Dave & Buster's Entertainment, Inc.

Triangle Icon
Dinesh C. Paliwal

Dinesh C. Paliwal

President and Chief Executive Officer, Harman International Industries, Inc.

Triangle Icon
Theodore R. Samuels

Theodore R. Samuels

Retired President of Capital Guardian Trust Company

Triangle Icon
Vicki L. Sato

Vicki L. Sato, Ph.D.

Retired Professor of Management Practice, Harvard Business School and Lead Independent Director, Bristol-Myers Squibb

Triangle Icon
Gerald L. Storch

Gerald L. Storch

Chief Executive Officer, Hudson's Bay Company

Triangle Icon